tiprankstipranks
Trending News
More News >
bioMerieux (GB:0RUG)
LSE:0RUG
UK Market

bioMerieux (0RUG) Ratios

Compare
2 Followers

bioMerieux Ratios

GB:0RUG's free cash flow for Q4 2024 was €0.54. For the 2024 fiscal year, GB:0RUG's free cash flow was decreased by € and operating cash flow was €0.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.20 2.03 1.96 2.29 1.80
Quick Ratio
1.29 1.19 1.28 1.61 1.19
Cash Ratio
0.40 0.32 0.49 0.84 0.42
Solvency Ratio
0.47 0.41 0.46 0.57 0.44
Operating Cash Flow Ratio
0.59 0.41 0.42 0.86 0.63
Short-Term Operating Cash Flow Coverage
5.98 3.27 2.95 11.01 5.58
Net Current Asset Value
€ 942.10M€ 698.20M€ 673.00M€ 743.20M€ 215.10M
Leverage Ratios
Debt-to-Assets Ratio
0.09 0.10 0.10 0.10 0.12
Debt-to-Equity Ratio
0.12 0.14 0.14 0.15 0.20
Debt-to-Capital Ratio
0.10 0.12 0.12 0.13 0.17
Long-Term Debt-to-Capital Ratio
0.05 0.06 0.06 0.08 0.09
Financial Leverage Ratio
1.37 1.40 1.44 1.48 1.62
Debt Service Coverage Ratio
5.82 5.08 4.26 9.86 5.07
Interest Coverage Ratio
36.80 99.80 136.54 84.40 22.14
Debt to Market Cap
0.03 0.03 0.03 0.02 0.03
Interest Debt Per Share
4.30 4.43 4.32 3.99 4.28
Net Debt to EBITDA
0.05 0.20 -0.06 -0.35 0.12
Profitability Margins
Gross Profit Margin
55.66%55.99%54.64%58.33%55.68%
EBIT Margin
14.96%12.03%15.44%22.43%16.65%
EBITDA Margin
22.55%22.52%22.62%28.96%23.98%
Operating Profit Margin
14.79%11.95%15.60%22.75%17.68%
Pretax Profit Margin
14.56%11.91%15.33%22.16%15.86%
Net Profit Margin
10.86%9.73%12.60%17.80%12.97%
Continuous Operations Profit Margin
10.68%8.79%12.27%17.74%12.92%
Net Income Per EBT
74.61%81.74%82.22%80.33%81.80%
EBT Per EBIT
98.39%99.64%98.29%97.43%89.70%
Return on Assets (ROA)
7.49%6.80%8.72%13.05%10.30%
Return on Equity (ROE)
10.28%9.53%12.55%19.31%16.63%
Return on Capital Employed (ROCE)
12.70%10.53%13.80%21.05%18.35%
Return on Invested Capital (ROIC)
9.04%7.48%10.56%16.40%14.34%
Return on Tangible Assets
9.50%8.87%15.41%21.06%18.07%
Earnings Yield
3.55%3.01%3.92%4.07%2.97%
Efficiency Ratios
Receivables Turnover
4.64 0.00 4.15 4.76 4.52
Payables Turnover
6.48 6.10 6.04 5.87 6.67
Inventory Turnover
1.70 1.78 2.12 2.17 2.46
Fixed Asset Turnover
2.35 2.44 2.62 2.76 2.92
Asset Turnover
0.69 0.70 0.69 0.73 0.79
Working Capital Turnover Ratio
3.20 3.34 3.10 3.43 6.20
Cash Conversion Cycle
236.87 145.20 199.66 182.69 174.49
Days of Sales Outstanding
78.65 0.00 87.99 76.65 80.71
Days of Inventory Outstanding
214.56 205.02 172.07 168.18 148.48
Days of Payables Outstanding
56.34 59.83 60.40 62.14 54.70
Operating Cycle
293.21 205.02 260.06 244.83 229.19
Cash Flow Ratios
Operating Cash Flow Per Share
5.67 3.77 4.03 6.97 4.93
Free Cash Flow Per Share
2.73 0.91 1.60 4.52 2.58
CapEx Per Share
2.94 2.87 2.43 2.45 2.35
Free Cash Flow to Operating Cash Flow
0.48 0.24 0.40 0.65 0.52
Dividend Paid and CapEx Coverage Ratio
1.50 1.02 1.22 2.27 1.94
Capital Expenditure Coverage Ratio
1.93 1.32 1.66 2.84 2.10
Operating Cash Flow Coverage Ratio
1.36 0.86 0.94 1.78 1.21
Operating Cash Flow to Sales Ratio
0.17 0.12 0.13 0.24 0.19
Free Cash Flow Yield
2.64%0.90%1.63%3.62%2.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
28.20 33.21 25.53 24.57 33.71
Price-to-Sales (P/S) Ratio
3.06 3.23 3.22 4.38 4.37
Price-to-Book (P/B) Ratio
2.90 3.17 3.20 4.75 5.61
Price-to-Free Cash Flow (P/FCF) Ratio
37.91 110.89 61.30 27.63 44.66
Price-to-Operating Cash Flow Ratio
18.27 26.66 24.31 17.91 23.39
Price-to-Earnings Growth (PEG) Ratio
1.34 -1.57 -1.05 0.51 0.70
Price-to-Fair Value
2.90 3.17 3.20 4.75 5.61
Enterprise Value Multiple
13.63 14.55 14.17 14.76 18.36
Enterprise Value
EV to EBITDA
13.63 14.55 14.17 14.76 18.36
EV to Sales
3.07 3.28 3.20 4.27 4.40
EV to Free Cash Flow
38.04 112.44 61.05 26.99 44.96
EV to Operating Cash Flow
18.33 27.04 24.21 17.50 23.55
Tangible Book Value Per Share
25.38 21.39 11.81 11.95 6.70
Shareholders’ Equity Per Share
35.71 31.78 30.56 26.32 20.58
Tax and Other Ratios
Effective Tax Rate
0.27 0.26 0.20 0.20 0.19
Revenue Per Share
33.80 31.13 30.43 28.55 26.39
Net Income Per Share
3.67 3.03 3.84 5.08 3.42
Tax Burden
0.75 0.82 0.82 0.80 0.82
Interest Burden
0.97 0.99 0.99 0.99 0.95
Research & Development to Revenue
0.12 0.13 0.12 0.11 0.13
SG&A to Revenue
0.08 0.08 0.07 0.07 0.06
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.57 1.25 1.05 1.37 1.44
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis